ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026
Phase 1 Study of KITE-222, an Autologous CLL-1-Directed CAR T-cell Therapy in Patients with Relapsed/Refractory Acute Myeloid Leukemia.
Naval Daver et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.